勾画方法对SIRT治疗HCC患者疗效及生存预测的剂量学影响
结果显示MRI勾画的Dm和TNR可预测肿瘤控制与总生存,严格临床工作流可行。
要点
- MRI勾画的TNR可预测6个月肿瘤控制(OR 5.9和7.1)。
- 治疗前所有剂量指标均预测OS,治疗后仅MRI勾画Dm预测OS(p=0.04)。
- 基于影像勾画加闪烁显像配准的严格工作流可行。
核心结论
- 在晚期HCC接受SIRT治疗中,基于放射学勾画的Dm和TNR可预测肿瘤控制和总生存。
研究设计与样本
- 靶区勾画采用两种方法:放射科医生手工MRI勾画后经形变配准至SPECT/CT和PET/CT(Pre-CMRI和Post-CMRI),以及99mTc-MAA-SPECT和90Y微球PET的10%阈值勾画(Pre-CSPECT和Post-CPET)。
主要发现
- 治疗前后Dm和TNR无显著差异。
- MRI勾画的TNR(Pre-CMRI和Post-CMRI)预测6个月肿瘤控制,OR分别为5.9和7.1(p=0.02和0.01)。
- 治疗前两种方法的所有剂量指标均预测总生存。
- 治疗后仅MRI勾画的Dm预测总生存,Dm高于中位者中位OS为23个月,低于中位者为14个月(p=0.04)。
关键数值与推荐
- MRI勾画TNR预测6个月肿瘤控制:Pre-CMRI的OR 5.9(p=0.02),Post-CMRI的OR 7.1(p=0.01)。
- 治疗后MRI勾画Dm高于中位者中位OS 23个月,低于中位者14个月(p=0.04)。
临床怎么用
- 建议采用严格临床工作流,即放射学勾画后配准至闪烁显像图像,以评估剂量指标并预测疗效。
- 该工作流应前瞻性考虑用于优化治疗策略。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: The aim of this study was to evaluate the impact of the contouring methods on dose metrics and their predictive value on tumor control and survival, in both situations of pre-treatment and post-treatment dosimetry, for patients with advanced HCC treated with SIRT. METHODS: Forty-eight patients who underwent SIRT between 2012 and 2020 were retrospectively included in this study. Target volumes were delineated using two methods: MRI-based contours manually drawn by a radiologist and then registered on SPECT/CT and PET/CT via deformable registration (Pre-CMRI and Post-CMRI), 99mTc-MAA-SPECT and 90Y-microspheres-PET 10% threshold contouring (Pre-CSPECT and Post-CPET). The mean absorbed dose (Dm) and the minimal absorbed dose delivered to 70% of the tumor volume (D70) were evaluated with both contouring methods; the tumor-to-normal liver uptake ratio (TNR) was evaluated with MRI-based contours only. Tumor response was assessed using the mRECIST criteria on the follow-up MRIs. RESULTS: No significant differences were found for Dm and TNR between pre- and post-treatment. TNR evaluated with radiologic contours (Pre-CMRI and Post-CMRI) were predictive of tumor control at 6 months on pre- and post-treatment dosimetry (OR 5.9 and 7.1, respectively; p = 0.02 and 0.01). All dose metrics determined with both methods were predictive of overall survival (OS) on pre-treatment dosimetry, but only Dm with MRI-based contours was predictive of OS on post-treatment images with a median of 23 months for patients with a supramedian Dm versus 14 months for the others (p = 0.04). CONCLUSION: In advanced HCC treated with SIRT, Dm and TNR determined with radiologic contours were predictive of tumor control and OS. This study shows that a rigorous clinical workflow (radiologic contours + registration on scintigraphic images) is feasible and should be prospectively considered for improving therapeutic strategy.
引用
- Nodari G, Popoff R, Riedinger JM, et al. Impact of contouring methods on pre-treatment and post-treatment dosimetry for the prediction of tumor control and survival in HCC patients treated with selective internal radiation therapy. EJNMMI Res. 2021. PMID: 33687596. doi:10.1186/s13550-021-00766-x
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。